Digital Content 
NEWS #PharmaBuzz
13 May 2025
// INDPHARMAPOST
https://www.indianpharmapost.com/drug-approval/zydus-receives-final-approval-from-usfda-for-glatiramer-acetate-injection-17138
10 May 2025
// ECONOMICTIMES
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/zydus-gets-usfda-nod-for-generic-drug-to-treat-multiple-sclerosis/articleshow/121019518.cms
08 May 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250508042178/en/Zydus-Receives-Final-Approval-From-USFDA-for-Glatiramer-Acetate-Injection-the-Generic-Version-of-Copaxone-20-mgml-40-mgml-Single-Dose-Prefilled-Syringes
07 May 2025
// FDA
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208468
23 Jan 2025
// FDA
https://www.fda.gov/safety/medical-product-safety-information/copaxone-glatopa-glatiramer-acetate-drug-safety-communication-fda-adds-boxed-warning-about-rare#:~:text=ISSUE%3A%20The%20FDA%20is%20warning,with%20multiple%20sclerosis%20(MS).
30 Oct 2024
// FIERCE PHARMA
https://www.fiercepharma.com/pharma/teva-slapped-eu463m-fine-over-accusations-it-stymied-copaxone-competition-europe
Share 